Skip to main content

St. Louis Court Rules In Favor Of Bayer In An Essure Lawsuit

St. Louis Court Rules In Favor Of Bayer In An Essure Lawsuit

St. Louis Court Rules In Favor Of Bayer In An Essure Lawsuit

Introduction

Bayer received good news beginning of the year as the Missouri Supreme Court ruled in its favor regarding an Essure Lawsuit filed by 92 women for injuries allegedly caused by the implanted Essure coils. The Missouri court ruled in the defendant’s favor stating it lacked jurisdiction over non-residents. This decision has affected the proceeding of this lawsuit in the Missouri Court for now as only seven out of the 92 plaintiffs were from Missouri. Bayer requested the court to transfer non-Missouri plaintiffs to appropriate venues and also stated that all claims were preempted by the federal law, which meant they were immune from the lawsuits because the FDA approved the medical device.

However, the plaintiffs have filed a petition stating that chief investigators for the device’s clinical studies were from Missouri, its national marketing campaign was based there, and clinical trials were conducted in this state. The Supreme Court judges have allowed the lower court to consider plaintiffs’ amended petition.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!